← Leaderboards
Deepak Nijhawan
Ut Southwestern Medical Center
$7,364,715
Attributed
$7,364,715
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2018–24$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,364,715 · 3
By mechanism
R37$2,774,141 · 1
R01$2,704,243 · 1
U54$1,886,331 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Ondine B Cleaver$13,138,322
- Thomas Joseph Carroll$11,853,604
- Igor A Butovich$6,243,090
- Matthew Ganio$58,843
- Bruce Arthur Posner$4,478,765
Others in their field
Other Emerging Leaders on “Small Molecule”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$32,426,535
- Xinhua Li · Nano Terra, Inc.$29,432,783
- Leonard Freedman · Leidos Biomedical Research, Inc.$14,890,784
- Alan Johnson · Hawaii Biotech, Inc.$14,045,226
Research focus
Small MoleculeCellsMalignant NeoplasmsTumorCancer TherapyCancer CellExperimental StudyClinical DevelopmentPharmaceutical PreparationsBindingAnti-CancerPre-Clinical ModelCancer Cell GrowthProteinsOncogenicGenesDrug TargetingPathway InteractionsResistanceAllelesCell DeathAnticancer ActivityCullin ProteinsCell Growth
Grant awards (15)
Understanding the mechanism of action for anticancer sulfonamides that target splicing$356,393
R37 · FY2024 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$367,647
R37 · FY2023 · CA · contact PI
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.$442,017
R01 · FY2022 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$366,647
R37 · FY2022 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$85,222
R37 · FY2022 · CA · contact PI
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.$562,022
R01 · FY2021 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$458,108
R37 · FY2021 · CA · contact PI
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.$562,022
R01 · FY2020 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$366,647
R37 · FY2020 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$51,183
R37 · FY2020 · CA · contact PI
Identification of Small Molecule Inhibitors of EWSR1-FLI1 Oncogenic Function$1,886,331
U54 · FY2019 · CA · contact PI
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.$545,160
R01 · FY2019 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$355,647
R37 · FY2019 · CA · contact PI
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.$593,022
R01 · FY2018 · CA · contact PI
Understanding the mechanism of action for anticancer sulfonamides that target splicing$366,647
R37 · FY2018 · CA · contact PI